HBOT and PTSD: What the Research Is Showing

Post-traumatic stress disorder is one of the most debilitating conditions a person can live with. It is also one of the most difficult to treat. Standard approaches, psychotherapy, medication, or a combination of both, help many patients, but a significant proportion do not achieve adequate relief. For this group, the search for additional options is not a lifestyle choice; it is a clinical necessity.

Hyperbaric oxygen therapy has emerged as a serious area of research in PTSD treatment, particularly in military and veteran populations. The findings are preliminary but credible, and they are attracting attention from researchers and clinicians who have spent careers working on this condition.

The Neurobiology Behind the Interest

PTSD is not simply a psychological response to trauma. It involves measurable changes in brain structure and function, changes that are visible on imaging and that correlate with the severity of symptoms.

Studies using SPECT and PET imaging have consistently shown reduced cerebral blood flow in specific brain regions in patients with PTSD, including the prefrontal cortex, the hippocampus, and the anterior cingulate cortex. These are areas involved in emotional regulation, memory processing, and the ability to distinguish present safety from past threat. Reduced perfusion in these regions is associated with the hypervigilance, intrusive memories, emotional numbing, and sleep disturbance that characterise the condition.

Neuroinflammation is also implicated. Trauma activates the brain's immune response, and in PTSD this activation appears to persist long after the acute event. Chronic neuroinflammation contributes to the structural and functional changes observed in the PTSD brain.

HBOT addresses both of these mechanisms. By increasing dissolved oxygen in plasma to levels that can reach poorly perfused brain tissue, it supports the metabolic function of neurons in hypoxic regions. It also has well-documented anti-inflammatory effects. And through repeated sessions, it stimulates angiogenesis, the growth of new blood vessels, which may improve baseline cerebral perfusion over time.

What the Research Shows

The most significant published work on HBOT and PTSD comes from a randomised controlled trial conducted at the Sagol Center for Hyperbaric Medicine and Research in Israel, published in 2023. Thirty-five veterans with treatment-resistant PTSD were randomised to either 60 sessions of HBOT at 2.0 ATA with 100% oxygen, or a sham control. The HBOT group showed significant reductions in PTSD symptom severity on validated clinical scales, alongside improvements in depression, anxiety, and quality of life. Brain imaging showed increased cerebral blood flow in the regions most affected by PTSD.

This is a small trial. It is also, notably, a trial in treatment-resistant patients, people who had already failed to respond adequately to standard care. The fact that meaningful improvements were observed in this population is clinically significant.

Earlier work from the same group had demonstrated improvements in PTSD symptoms in a cohort of veterans with mild traumatic brain injury and comorbid PTSD, suggesting that the two conditions, which frequently co-occur, may both respond to HBOT through overlapping mechanisms.

Research in the United States has also been advancing. The Department of Defense and the Veterans Administration have funded studies examining HBOT in veteran populations with PTSD and traumatic brain injury. Results from several of these trials are expected in the coming years.

The Overlap with Traumatic Brain Injury

It is worth noting that PTSD and mild traumatic brain injury (mTBI) frequently co-occur, particularly in military populations. The distinction between the two conditions is not always clean, both involve changes in brain function, both present with overlapping symptoms, and both are associated with reduced cerebral blood flow in similar regions.

This overlap is relevant to HBOT research because the mechanisms by which HBOT may help are similar in both conditions. Several studies have examined HBOT in patients with comorbid PTSD and mTBI, and the results have generally been positive for both sets of symptoms. For patients who have experienced both trauma and head injury, a common combination in combat veterans and survivors of accidents or violence, HBOT may address both conditions simultaneously.

What a Protocol Looks Like

The protocols used in PTSD research have generally involved 60 sessions at 2.0 ATA, breathing 100% oxygen, with each session lasting 90 minutes. As with dementia and long COVID protocols, this is a substantial commitment, approximately 12 weeks of daily treatment on weekdays.

PTSD patients face particular considerations that are worth acknowledging. The enclosed environment of a hyperbaric chamber can be challenging for patients with claustrophobia, which is not uncommon in trauma survivors. Reputable facilities will assess this carefully before treatment begins and have protocols for managing anxiety in the chamber. For most patients, the experience becomes more comfortable over the course of treatment, but this is a conversation to have with the clinical team before committing to a course.

The clinical decisions about suitability, protocol, and monitoring belong to the treating physician and, where relevant, the patient's existing mental health team. HBOT for PTSD should be pursued as part of a coordinated care plan, not as a replacement for psychological treatment.

The Honest Limitations

The evidence for HBOT in PTSD is promising and mechanistically coherent. It is not yet sufficient to establish HBOT as a standard treatment for the condition.

The published trials are small and largely from a single research group. Independent replication in larger populations is needed. The patient populations studied have been predominantly military veterans, a group with specific trauma profiles and frequent comorbidities, and it is not yet clear how well the findings generalise to civilian PTSD populations with different trauma histories.

The question of which patients are most likely to respond is also unresolved. PTSD is a heterogeneous condition, and the neurobiological profile of one patient may differ substantially from another. Imaging-guided patient selection, identifying patients with the specific patterns of reduced cerebral blood flow that HBOT is most likely to address, may prove important, but this approach is not yet standard practice.

Who Is Pursuing This Treatment

People considering HBOT for PTSD tend to fall into two broad groups.

The first are veterans or first responders who have been living with PTSD for years, have engaged seriously with conventional treatment, and are looking for options that address the neurobiological dimension of their condition rather than the psychological dimension alone. For this group, the research in military populations is directly relevant.

The second are civilians, survivors of accidents, medical trauma, violence, or other adverse experiences, who have a PTSD diagnosis and are exploring what is available beyond standard care. For this group, the evidence base is less specific, but the mechanisms are the same.

Both groups deserve an honest account of what the research supports and what it does not, and access to facilities that have genuine experience with PTSD protocols rather than simply offering HBOT as a general wellness service.

Accessing Treatment

Hard shell HBOT at the pressures used in PTSD research is available through specialist hyperbaric centres internationally. As with other neurological and psychiatric applications, the quality of clinical oversight varies considerably between facilities.

For PTSD specifically, the relationship between the hyperbaric team and the patient's existing mental health providers matters. A course of HBOT that surfaces difficult material, as any effective trauma treatment may, needs to be supported by appropriate psychological care. Facilities that treat PTSD in isolation from the broader mental health context are not providing the standard of care that this patient population requires.

For anyone considering HBOT for PTSD, understanding which facilities have genuine experience with this indication and how they coordinate with mental health care is the right place to start.